Bleeding and Thrombotic Adverse Events in Hospitalized Patients Under Empiric Treatment for Suspected Heparin-Induced Thrombocytopenia While Awaiting Confirmatory Testing.

Dykes, Kaitlyn C; Johnson, Cassandra A; Gong, Jerald Z; McKenzie, Steven E; Husseinzadeh, Holleh D

Dykes, Kaitlyn C; Johnson, Cassandra A; Gong, Jerald Z; McKenzie, Steven E; Husseinzadeh, Holleh D.

Dykes KC; 12231Georgetown University Medical Center, Washington, DC, USA.
Johnson CA; Biostatistics, 5635University of Minnesota, Minneapolis, MN, USA.
Gong JZ; Hematopathology, 23217Thomas Jefferson University Hospital, Philadelphia, PA, USA.
McKenzie SE; Hematology, 23217Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Husseinzadeh HD; Hematology, 23217Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Clin Appl Thromb Hemost ; 27: 1076029621996473, 2021.

Article en En | MEDLINE | ID: mdl-33848189

Asunto(s)

Heparina/efectos adversos; Trombocitopenia/inducido químicamente; Trombosis/complicaciones; Femenino; Hemorragia; Humanos; Masculino; Persona de Mediana Edad; Estudios Retrospectivos

Palabras clave

adverse event; anticoagulants; direct thrombin inhibitor; factor Xa inhibitors; heparin-induced thrombocytopenia; thrombosis

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Trombosis / Heparina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google